Oral anticoagulants and antithrombin IIi
Frost, T.; Loveday, D.
Medical Journal of Australia 2(4): 220
1980
ISSN/ISBN: 0025-729X PMID: 7432294 Document Number: 164425
Document emailed within 1 workday
Related Documents
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893Nighoghossian, N.; Ffrench, P.; Massignon, D.; Trouillas, P. 1990: Intracranial hematoma in a patient with antithrombin III deficiency treated with anticoagulants. Early prevention of thromboembolic complications Presse Medicale 19(24): 1155
Duck, H.J.; Köhler, H.; Trenckmann, H.; Fiedler, G. 1979: Determination of serum antithrombins for the determination of plasmatic hypercoagulability in acute cardiovascular diseases. II. Normal values of antithrombin capacity and the in vivo effect of anticoagulants and streptokinase in humans and frequently used laboratory animals Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(5): 133-138
Neuzil, K.M.; Morgan, H.J. 1991: Hemarthrosis and oral anticoagulants Journal of the Tennessee Medical Association 84(4): 180-181
Le Mao, R.ël.; Tromeur, C.éc.; Fofana, A.; Leroyer, C.; Lacut, K. 2018: Direct oral anticoagulants La Revue du Praticien 68(5): 475-482
2010: INR self-monitoring and oral anticoagulants Prescrire International 19(107): 130-132
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
De Moerloose, P.; Casini, A.; Boehlen, F.; Fontana, P. 2013: New oral anticoagulants: from theory to practice Revue Medicale Suisse 9(369): 104-107
Prins, M.H.; ten Cate, J.W. 1996: Optimal treatment with oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 140(20): 1059-1061
Hitzeman, N.; Applebaum, S. 2008: Oral anticoagulants vs. antiplatelet therapy American Family Physician 77(9): 1250-1252
Erich, W.B.; van der Meer, F.J. 1996: Optimal treatment with oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 140(36): 1830-1831
Jullian, M.; Youlton, R.; Rivera, L. 1983: Embryopathy induced by oral anticoagulants Revista Medica de Chile 111(10): 1045-1048
Wehrlin, N. 1974: Oral anticoagulants: anti-vitamin K Revue de l'Infirmiere 24(5): 475-480
Lourenço, D.M.; Morelli, V.M.; Vignal, C.V. 1998: Treatment for overdose of oral anticoagulants Arquivos Brasileiros de Cardiologia 70(1): 9-13
Hohmann, C.; Neumann-Haefelin, T.; Radziwill, R.; Benöhr, P. 2015: Novel oral anticoagulants--issues in clinical practice Medizinische Monatsschrift für Pharmazeuten 38(10): 374-385; Quiz: 387-388
D'Angelo, A.; Crippa, L.; Agazzi, A.; Della Valle, P.; Anzalone, N.; Garlando, A.M.; D'Angelo, S.V. 1995: Oral anticoagulants: old drugs with a promising future Haematologica 80(2 Suppl): 92-101
Cervin, A.; Billström, R. 1992: Hemorrhagic complications of oral anticoagulants--who is affected and why? Lakartidningen 89(15): 1292-1294
2014: Current Indian scenario on the use of oral anticoagulants Journal of the Association of Physicians of India 62(6 Suppl): 28-29
Lunde, I.; Lunde, P.K. 1971: Drugs which can influence the effect of oral anticoagulants Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 1971: Suppl 18: 1-8
O'Reilly, R.A. 1974: Drug interactions involving oral anticoagulants Cardiovascular Clinics 6(2): 23-41